The University of Chicago Header Logo

Connection

Sarosh Rana to Pregnancy

Back to Details
This is a "connection" page, showing publications Sarosh Rana has written about Pregnancy.
Sarosh Rana
Connection Strength
7.014
Pregnancy
  1. Neuropsychological performance in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 2006 Jul; 195(1):186-91.
    View in: PubMed
    Score: 0.167
  2. Luteolin prevents TNF-a-induced NF-?B activation and ROS production in cultured human placental explants and endothelial cells. Placenta. 2024 Jan; 145:65-71.
    View in: PubMed
    Score: 0.143
  3. COVID-19 and obstetric outcomes: a single-center retrospective experience in a predominantly Black population. J Matern Fetal Neonatal Med. 2023 Dec; 36(1):2196364.
    View in: PubMed
    Score: 0.142
  4. Patient and provider perception of home blood pressure monitoring kits. Pregnancy Hypertens. 2023 Dec; 34:33-38.
    View in: PubMed
    Score: 0.141
  5. Angiogenic Biomarkers for Preeclampsia in Clinical Setting: A New Era. Hypertension. 2023 10; 80(10):2029-2032.
    View in: PubMed
    Score: 0.140
  6. Bioflavonoid luteolin prevents sFlt-1 release via HIF-1a inhibition in cultured human placenta. FASEB J. 2023 08; 37(8):e23078.
    View in: PubMed
    Score: 0.139
  7. Reducing the Risk of Term Preeclampsia by Risk-Stratified Timing of Birth: Time to Deliver. Hypertension. 2023 05; 80(5):979-980.
    View in: PubMed
    Score: 0.136
  8. A Comparison of Obstetric Interventions and Outcomes Between Black and White Patients at an Urban Tertiary Medical Center. Reprod Sci. 2023 07; 30(7):2313-2323.
    View in: PubMed
    Score: 0.134
  9. Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states. Pregnancy Hypertens. 2022 Aug; 29:108-115.
    View in: PubMed
    Score: 0.129
  10. Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia. Clin Chem. 2022 06 01; 68(6):771-781.
    View in: PubMed
    Score: 0.128
  11. Racial Differences in Readmissions in Hypertensive Disorders of Pregnancy. Reprod Sci. 2022 07; 29(7):2071-2078.
    View in: PubMed
    Score: 0.127
  12. Women's perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia. Pregnancy Hypertens. 2022 Jun; 28:109-113.
    View in: PubMed
    Score: 0.126
  13. Racial Disparities in Diagnosis, Management, and Outcomes in Preeclampsia. Curr Hypertens Rep. 2022 04; 24(4):87-93.
    View in: PubMed
    Score: 0.126
  14. Elimination of racial disparities in postpartum hypertension follow-up after incorporation of telehealth into a quality bundle. Am J Obstet Gynecol MFM. 2022 05; 4(3):100580.
    View in: PubMed
    Score: 0.125
  15. Prevalence and management of severe intrapartum hypertension in patients with preeclampsia at an urban tertiary care medical center. Pregnancy Hypertens. 2022 Mar; 27:87-93.
    View in: PubMed
    Score: 0.125
  16. Postpartum Outcomes With Systematic Treatment and Management of Postpartum Hypertension. Obstet Gynecol. 2021 11 01; 138(5):777-787.
    View in: PubMed
    Score: 0.123
  17. Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States. Pregnancy Hypertens. 2021 Dec; 26:121-126.
    View in: PubMed
    Score: 0.123
  18. Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension. Hypertension. 2021 09; 78(4):927-935.
    View in: PubMed
    Score: 0.121
  19. The interval between births and the risk of recurrent preeclampsia among predominantly high risk women in urban tertiary care center. Pregnancy Hypertens. 2021 Aug; 25:7-11.
    View in: PubMed
    Score: 0.119
  20. Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction. Am J Obstet Gynecol MFM. 2021 07; 3(4):100394.
    View in: PubMed
    Score: 0.119
  21. Real-World Use of Biomarkers in Management of Hypertension During Pregnancy: Adjunct to Clinical Care. Hypertension. 2021 02; 77(2):472-474.
    View in: PubMed
    Score: 0.117
  22. Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study. Pregnancy Hypertens. 2021 Mar; 23:97-103.
    View in: PubMed
    Score: 0.116
  23. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol. 2022 02; 226(2S):S1019-S1034.
    View in: PubMed
    Score: 0.115
  24. Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia. Pregnancy Hypertens. 2020 Jul; 21:124-131.
    View in: PubMed
    Score: 0.112
  25. Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension. Pregnancy Hypertens. 2020 Apr; 20:124-130.
    View in: PubMed
    Score: 0.111
  26. Effect of blood pressure control in early pregnancy and clinical outcomes in African American women with chronic hypertension. Pregnancy Hypertens. 2020 Apr; 20:102-107.
    View in: PubMed
    Score: 0.110
  27. Severe antepartum hypertension and associated peripartum morbidity among pregnant women in an urban tertiary care medical center. Pregnancy Hypertens. 2020 Jan; 19:31-36.
    View in: PubMed
    Score: 0.108
  28. Understanding and comparing practices of managing patients with hypertensive disorders of pregnancy in urban China and the United States. Pregnancy Hypertens. 2019 Jul; 17:253-260.
    View in: PubMed
    Score: 0.105
  29. Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients. Hypertension. 2019 04; 73(4):868-877.
    View in: PubMed
    Score: 0.103
  30. Preeclampsia: Pathophysiology, Challenges, and Perspectives Circ Res. 2019 03 29; 124(7):1094-1112.
    View in: PubMed
    Score: 0.103
  31. Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension. Pregnancy Hypertens. 2018 Oct; 14:110-114.
    View in: PubMed
    Score: 0.099
  32. Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy. Hypertension. 2018 07; 72(1):188-193.
    View in: PubMed
    Score: 0.097
  33. Angiogenic biomarkers in triage and risk for preeclampsia with severe features. Pregnancy Hypertens. 2018 Jul; 13:100-106.
    View in: PubMed
    Score: 0.097
  34. Abnormal mid-trimester cardiac strain in women with chronic hypertension predates superimposed preeclampsia. Pregnancy Hypertens. 2017 Oct; 10:251-255.
    View in: PubMed
    Score: 0.093
  35. Prevalence, risk factors and associated complications of postpartum hypertension in rural Haiti. Pregnancy Hypertens. 2017 Oct; 10:135-142.
    View in: PubMed
    Score: 0.092
  36. Angiogenic Proteins: Can These Biomarkers Help to Prevent Maternal Deaths Related to Preeclampsia? Hypertension. 2017 03; 69(3):401-403.
    View in: PubMed
    Score: 0.089
  37. Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension. 2016 06; 67(6):1273-80.
    View in: PubMed
    Score: 0.084
  38. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes. Hypertens Pregnancy. 2016 Aug; 35(3):330-45.
    View in: PubMed
    Score: 0.084
  39. Sequential plasma angiogenic factors levels in women with suspected preeclampsia. Am J Obstet Gynecol. 2016 Jul; 215(1):89.e1-89.e10.
    View in: PubMed
    Score: 0.083
  40. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation. 2015 Nov 03; 132(18):1726-33.
    View in: PubMed
    Score: 0.081
  41. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. PLoS One. 2015; 10(5):e0126815.
    View in: PubMed
    Score: 0.079
  42. Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenat Diagn. 2015 Apr; 35(4):386-93.
    View in: PubMed
    Score: 0.077
  43. Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia". Hypertens Pregnancy. 2014 Nov; 33(4):525.
    View in: PubMed
    Score: 0.074
  44. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy. 2014 Nov; 33(4):427-39.
    View in: PubMed
    Score: 0.074
  45. Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1a pathway. FASEB J. 2014 Oct; 28(10):4324-34.
    View in: PubMed
    Score: 0.074
  46. Angiogenic factors in preeclampsia: potential for diagnosis and treatment. Curr Opin Nephrol Hypertens. 2013 Nov; 22(6):643-50.
    View in: PubMed
    Score: 0.071
  47. Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension. 2014 Feb; 63(2):198-202.
    View in: PubMed
    Score: 0.071
  48. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy. 2013 May; 32(2):189-201.
    View in: PubMed
    Score: 0.068
  49. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One. 2012; 7(10):e48259.
    View in: PubMed
    Score: 0.066
  50. Circulating lymphangiogenic factors in preeclampsia. Hypertens Pregnancy. 2013; 32(1):42-9.
    View in: PubMed
    Score: 0.065
  51. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension. 2012 Aug; 60(2):451-8.
    View in: PubMed
    Score: 0.065
  52. Management of abnormal serum markers in the absence of aneuploidy or neural tube defects. J Matern Fetal Neonatal Med. 2012 Oct; 25(10):1895-8.
    View in: PubMed
    Score: 0.063
  53. Angiogenic factors and pregnant woman with new onset seizures. Hypertens Pregnancy. 2012; 31(2):207-10.
    View in: PubMed
    Score: 0.063
  54. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012 Feb 21; 125(7):911-9.
    View in: PubMed
    Score: 0.063
  55. Placental origins of angiogenic dysfunction in mirror syndrome. Hypertens Pregnancy. 2012; 31(2):211-7.
    View in: PubMed
    Score: 0.062
  56. Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy. 2012; 31(1):50-8.
    View in: PubMed
    Score: 0.059
  57. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010 Jun; 37(2):239-53.
    View in: PubMed
    Score: 0.056
  58. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med. 2010 May; 23(5):366-70.
    View in: PubMed
    Score: 0.056
  59. Rupture of the posterior cul-de-sac during spontaneous labor. Obstet Gynecol. 2010 Feb; 115(2 Pt 2):414-417.
    View in: PubMed
    Score: 0.055
  60. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007 Jul; 50(1):137-42.
    View in: PubMed
    Score: 0.045
  61. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol. 2007 Feb; 109(2 Pt2):549-52.
    View in: PubMed
    Score: 0.044
  62. Association of activin A and postpartum blood pressure in peripartum cardiomyopathy. Pregnancy Hypertens. 2023 Dec; 34:60-66.
    View in: PubMed
    Score: 0.035
  63. Single cell profiling at the maternal-fetal interface reveals a deficiency of PD-L1+?non-immune cells in human spontaneous preterm labor. Sci Rep. 2023 05 16; 13(1):7903.
    View in: PubMed
    Score: 0.034
  64. Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy. NEJM Evid. 2022 Dec; 1(12):EVIDoa2200161.
    View in: PubMed
    Score: 0.033
  65. The additive role of angiogenic markers for women with confirmed preeclampsia. Am J Obstet Gynecol. 2023 05; 228(5):573.e1-573.e11.
    View in: PubMed
    Score: 0.033
  66. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022 02; 79(2):e21-e41.
    View in: PubMed
    Score: 0.031
  67. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2022 Mar; 27:42-50.
    View in: PubMed
    Score: 0.031
  68. Is Prolonging Gestation in Preeclampsia For Better or Worse in Preventing Cardiovascular Disease? Hypertension. 2021 11; 78(5):1395-1397.
    View in: PubMed
    Score: 0.031
  69. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022 Mar; 27:148-169.
    View in: PubMed
    Score: 0.031
  70. Angiogenic factors and prediction for ischemic placental disease in future pregnancies. Pregnancy Hypertens. 2021 Aug; 25:12-17.
    View in: PubMed
    Score: 0.030
  71. Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy. Circulation. 2021 05 11; 143(19):1852-1862.
    View in: PubMed
    Score: 0.030
  72. Long-Term Postpartum Cardiac Function and Its Association With Preeclampsia. J Am Heart Assoc. 2021 02; 10(5):e018526.
    View in: PubMed
    Score: 0.029
  73. Transcriptome and regulatory maps of decidua-derived stromal cells inform gene discovery in preterm birth. Sci Adv. 2020 12; 6(49).
    View in: PubMed
    Score: 0.029
  74. Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats. Pregnancy Hypertens. 2021 Mar; 23:11-17.
    View in: PubMed
    Score: 0.029
  75. Derivation of endometrial gland organoids from term placenta. Placenta. 2020 11; 101:75-79.
    View in: PubMed
    Score: 0.028
  76. Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women. J Am Heart Assoc. 2020 06 16; 9(12):e015997.
    View in: PubMed
    Score: 0.028
  77. Surgical Excision of a Left Atrial Myxoma During the Second Trimester of Pregnancy. J Cardiothorac Vasc Anesth. 2020 Feb; 34(2):530-536.
    View in: PubMed
    Score: 0.027
  78. Hypertensive Diseases of Pregnancy Increase Risk of Readmission With Heart Failure: A National Readmissions Database Study. Mayo Clin Proc. 2019 05; 94(5):811-819.
    View in: PubMed
    Score: 0.025
  79. Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform. Pregnancy Hypertens. 2018 Jan; 11:66-70.
    View in: PubMed
    Score: 0.024
  80. Household air pollution and chronic hypoxia in the placenta of pregnant Nigerian women: A randomized controlled ethanol Cookstove intervention. Sci Total Environ. 2018 Apr 01; 619-620:212-220.
    View in: PubMed
    Score: 0.023
  81. Outcomes and mortality in parturient and non-parturient patients with peripartum cardiomyopathy: A national readmission database study. Pregnancy Hypertens. 2017 Oct; 10:143-148.
    View in: PubMed
    Score: 0.023
  82. Household air pollution and angiogenic factors in pregnant Nigerian women: A randomized controlled ethanol cookstove intervention. Sci Total Environ. 2017 Dec 01; 599-600:2175-2181.
    View in: PubMed
    Score: 0.023
  83. Increased Perinatal Morbidity and Mortality Among Asian American and Pacific Islander Women in the United States. Anesth Analg. 2017 03; 124(3):879-886.
    View in: PubMed
    Score: 0.022
  84. Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors. Hypertens Pregnancy. 2017 May; 36(2):161-167.
    View in: PubMed
    Score: 0.022
  85. Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample. Hypertens Pregnancy. 2017 May; 36(2):117-123.
    View in: PubMed
    Score: 0.022
  86. Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy. Pregnancy Hypertens. 2016 Oct; 6(4):333-339.
    View in: PubMed
    Score: 0.021
  87. Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1. Pregnancy Hypertens. 2016 Oct; 6(4):313-319.
    View in: PubMed
    Score: 0.021
  88. Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. JACC Heart Fail. 2016 05; 4(5):380-8.
    View in: PubMed
    Score: 0.021
  89. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016 Jan; 214(1):108.e1-108.e14.
    View in: PubMed
    Score: 0.020
  90. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014 Feb; 33(1):81-92.
    View in: PubMed
    Score: 0.018
  91. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertens Pregnancy. 2014 May; 33(2):250-9.
    View in: PubMed
    Score: 0.018
  92. The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med. 2013 Sep 01; 41(5):511-6.
    View in: PubMed
    Score: 0.017
  93. Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging. 2012 Nov; 5(6):734-9.
    View in: PubMed
    Score: 0.016
  94. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012 May 09; 485(7398):333-8.
    View in: PubMed
    Score: 0.016
  95. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension. 2012 Feb; 59(2):256-64.
    View in: PubMed
    Score: 0.016
  96. Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery. J Matern Fetal Neonatal Med. 2012 Jul; 25(7):1135-41.
    View in: PubMed
    Score: 0.015
  97. Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am J Clin Nutr. 2011 Dec; 94(6 Suppl):1980S-1985S.
    View in: PubMed
    Score: 0.015
  98. Placental expression of angiogenic factors in Trisomy 13. Am J Obstet Gynecol. 2011 Jun; 204(6):546.e1-4.
    View in: PubMed
    Score: 0.015
  99. Preeclampsia and the risk of large-for-gestational-age infants. Am J Obstet Gynecol. 2011 May; 204(5):425.e1-6.
    View in: PubMed
    Score: 0.015
  100. Midpregnancy levels of angiogenic markers in relation to maternal characteristics. Am J Obstet Gynecol. 2011 Mar; 204(3):244.e1-12.
    View in: PubMed
    Score: 0.014
  101. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010 Oct; 56(4):758-63.
    View in: PubMed
    Score: 0.014
  102. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol. 2010 Mar; 202(3):299.e1-7.
    View in: PubMed
    Score: 0.014
  103. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 2009 Jun; 24:147-58.
    View in: PubMed
    Score: 0.013
  104. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med. 2009 Apr; 22(4):293-9.
    View in: PubMed
    Score: 0.013
  105. Circulating soluble endoglin and placental abruption. Prenat Diagn. 2008 Sep; 28(9):852-8.
    View in: PubMed
    Score: 0.012
  106. Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis. Am J Kidney Dis. 2008 Jun; 51(6):1029-32.
    View in: PubMed
    Score: 0.012
  107. Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes. Diabetes Care. 2007 Feb; 30(2):375-7.
    View in: PubMed
    Score: 0.011
  108. Fetal cheek-to-cheek diameter in the prediction of mode of delivery. Am J Obstet Gynecol. 2005 Apr; 192(4):1205-11; discussion 1211-3.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.